Vermilion Energy Inc. (VET)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 19.46 |
|---|---|
| 52-week range | 10.08 – 20.31 |
| Return, 1 month / 3 months | +18.1% / +23.8% |
| Return, 1 year / 3 years | +89.5% / +8.2% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 48.4% |
| Worst drawdown (1 year) | -36.8% |
| Average daily value traded | 18.23M CAD |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vermilion Energy Inc. is an oil and gas company based in Calgary, Alberta. It explores for and produces crude oil, natural gas and natural gas liquids from properties in Canada, the United States, Europe and Australia. The company supplies these energy commodities to refiners, industrial users and energy traders in the markets where it operates, and it also runs midstream and processing infrastructure tied to its production.
Vermilion Energy Inc. trades under the code VET on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vermilion Energy Inc. (VET) trades on the Toronto Exchange in Canada. It last closed at CAD 19.46 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 132 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 89.5% and over the last three months it rose 23.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.0% | ||
| From 52-week high | -1.9% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.8% | ||
| 6-month return | 15.7% | ||
| 12-month return, skipping the last month | 60.5% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.8% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 18.23M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.3% |
|---|---|
| 1 month | +18.1% |
| 3 months | +23.8% |
| 6 months | +15.7% |
| 1 year | +89.5% |
| 3 years | +8.2% |
| 5 years | +64.7% |
Signals
| 50-day / 200-day average | 17.39 / 15.69 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | CAD 0.1350 |
| 15 Jun 2026 | CAD 0.1350 |
| 13 Mar 2026 | CAD 0.1350 |
| 15 Dec 2025 | CAD 0.1300 |
| 29 Sep 2025 | CAD 0.1300 |
| 30 Jun 2025 | CAD 0.1300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.